Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2009
11/05/2009US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
11/05/2009US20090274625 Compositions and Methods for The Treatment of Cancer
11/05/2009US20090274620 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
11/05/2009CA2726007A1 Vaccine compositions and methods
11/05/2009CA2723449A1 Methods and compositions for modulating angiogenesis and pericyte composition
11/05/2009CA2723315A1 Vascular delivery systems
11/05/2009CA2723143A1 Methods and compositions for prostate cancer immunotherapy
11/05/2009CA2723079A1 Novel triazole derivatives, their preparation and their application in therapeutics
11/05/2009CA2723042A1 Disubstituted phthalazine hedgehog pathway antagonists
11/05/2009CA2722854A1 Restoration of estrogen receptor-.alpha. activity
11/05/2009CA2722753A1 Pregesteron antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
11/05/2009CA2722637A1 Progesterone antagonists such as cdb-4124 in the treatment of breast cancer
11/05/2009CA2722426A1 Methods of using corticotropin-releasing factor for the treatment of cancer
11/05/2009CA2722220A1 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009CA2721614A1 Cytotoxic immunoglobulin
11/05/2009CA2717987A1 Inhibitors of gm-csf and il-17 for therapy
11/04/2009EP2113569A1 Recombinant adenoviral vector and methods of use
11/04/2009EP2113566A1 Genes from 20q13 amplicon and their uses
11/04/2009EP2113517A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof
11/04/2009EP2113508A1 Novel triazole nucleoside derivatives, their preparation and their application in therapeutics
11/04/2009EP2113257A1 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/04/2009EP2113255A1 Cytotoxic immunoglobulin
11/04/2009EP2113253A1 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
11/04/2009EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009EP2112990A2 Fluorocombretastatin and derivatives thereof
11/04/2009EP1704147B1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1533304B1 Amide derivative
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009EP1490121B1 Drug delivery particle
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1480736B1 Microcapsules having high carotenoid content
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009EP1366040B1 Amorphous form of cell cycle inhibitor
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009EP1004299B1 Vaccine precursors, vaccines for treating tumors
11/04/2009CN101573363A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/04/2009CN101573360A Heteroaryl compounds, compositions thereof, and methods of treatment therewith
11/04/2009CN101573108A Particles of paclitaxel and albumin in combination with bevacizumab against cancer
11/04/2009CN101569631A Anti tumor application of 3-carbonyl-20alpha-hydroxy-24-en-dammarane compound
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612213 (E)-ethyl 7-hydroxy-2-methyl-2-heptenate; (3E, 5E)-tert-butyl-9-(tert-butyldimethylsiloxy)-2-[(E)-ethylid ene]-4-methylnona-3,5-dienate
11/03/2009US7612202 Process for preparing temozolomide
11/03/2009US7612114 Selective estrogen receptor modulator
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612083 Urea substituted imidazoquinoline ethers
11/03/2009US7612081 Such as tert-butylester of 20S-(4-{[3-(7-camptothecinylidene-amino)-propyl]-tert-butoxycarbonyl-amino}-butyl)-(3-tert-butoxycarbonylaminopropyl)-carbamic acid; topoisomerase I inhibiting activity and useful for treatment of tumors and viral and parasite infections
11/03/2009US7612079 2-(hydroxypiperidin-1-yl or hydroxyisoalkylamino)-6(3-nitrophenylamino, 3,4-dimethoxybenzylamino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino)-9-(isopropyl or cyclopentyl)purines; cell cyclin kinase inhibitors for treating cancer, leukemia, psoriasis and neuronal apoptosis
11/03/2009US7612077 Crystalline forms of the anti-cancer compound ZD1839
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612062 Pyrrolobenzodiazepines
11/03/2009US7612052 Combinations comprising epothilones and pharmaceutical uses thereof
11/03/2009US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009US7612035 Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
11/03/2009US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009US7612032 Parenterally injecting bovine pancreatic DNAse to destroy extracellular DNA in systemic blood circulation of cancer patient slow down malignancy; treating lung carcinomas
11/03/2009US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009US7611729 Dosage forms having prolonged active ingredient release
11/03/2009US7611721 Adjuvant combination formulations
11/03/2009US7611720 Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
11/03/2009US7611715 Agaricus extract for preventing the induction or metastasis of cancer
11/03/2009US7611711 VEGFR-3 inhibitor materials and methods
11/03/2009US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2435524C Use of hederagenin 3-o-.alpha.-l-rhamnopyranosyl((1->2)-[.beta.-d-glucopyranosyl(1->4)]-.alpha.-l-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
11/03/2009CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009CA2356896C Method for high yield extraction of paclitaxel from paclitaxel-containing material
11/03/2009CA2205379C Yeast-based delivery vehicles
11/03/2009CA2187626C Aav-mediated delivery of dna to cells of the nervous system
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
11/03/2009CA2105618C Humanized antibodies to ganglioside gm2
10/2009
10/29/2009WO2009132234A2 Medical devices, polymers, compositions, and methods for delivering a haloacetate
10/29/2009WO2009131940A1 Limk2 inhibitors, compositions comprising them, and methods of their use
10/29/2009WO2009131687A2 Inhibitors of protein kinases
10/29/2009WO2009131453A1 Compositions and methods to enhance the immune system.
10/29/2009WO2009131263A1 Composition for cancer chemoprevention comprising the extracts of cutleria cylindrica
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131191A1 Metastin derivative and use thereof
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131171A1 Novel five-membered ring compound
10/29/2009WO2009131170A1 Five-membered ring compound
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130893A1 Method of detecting bladder cancer
10/29/2009WO2009130564A1 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias
10/29/2009WO2009130487A1 Aryl-quinolyl compounds and their use
10/29/2009WO2009130469A1 Dna-pk inhibitors
10/29/2009WO2009130453A1 Inhibitors of plk
10/29/2009WO2009130422A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009WO2009130296A2 Anti-alk1 antibodies and uses thereof
10/29/2009WO2009130016A1 Dihydropteridinones as plk inhibitors
10/29/2009WO2009130015A1 Improved raf inhibitors
10/29/2009WO2009129980A1 Method for the prevention and treatment of cancer by inhibition of gpvi
10/29/2009WO2009129938A1 Substituted phenoxybenzamides
10/29/2009WO2009129905A1 Pyridazinone derivatives
1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 2211